Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion type Assertion NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_head.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion evidence source_evidence_literature NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion SIO_000772 23905897 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion wasDerivedFrom befree-2016 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion wasGeneratedBy ECO_0000203 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.